(Q43146785)

14 November 2017

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. (English)

1 reference

invasive fungal infections

14 November 2017

1 reference

6

P Ljungman

1 reference

14 November 2017

7

J Mattsson

1 reference

14 November 2017

O Blennow

1

1 reference

14 November 2017

M Remberger

2

1 reference

14 November 2017

L Klingspor

3

1 reference

14 November 2017

B Omazic

4

1 reference

14 November 2017

K Fransson

5

1 reference

14 November 2017

O Ringdén

8

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Bone Marrow Transplantation

14 November 2017

1 reference

14 November 2017

45

1 reference

14 November 2017

12

1 reference

14 November 2017

1710-1718

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.38

14 November 2017

0 references

cites work

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Automated extraction of genomic DNA from medically important yeast species and filamentous fungi by using the MagNA Pure LC system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Immunohistochemistry for the diagnosis of aspergillosis in Turkey poults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

A Proportional Hazards Model for the Subdistribution of a Competing Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Infectious Complications Associated with Alemtuzumab Use for Lymphoproliferative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

Cefmenoxime Efficacy, Safety, and Pharmacokinetics in Critical Care Patients with Nosocomial Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Pulmonary aspergillosis: early diagnosis improves survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Polymerase chain reaction screening for fungemia and/or invasive fungal infections in patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.38

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.38

1 reference

Dimensions Publication ID

14 November 2017

0 references

1 reference